UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 149 filers reported holding UNIQURE NV in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $997,944 | -41.7% | 148,725 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $1,712,674 | -43.1% | 149,448 | -0.0% | 0.00% | -50.0% |
| Q1 2023 | $3,010,890 | -13.2% | 149,498 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $3,469,440 | +52.7% | 153,041 | +26.4% | 0.00% | +100.0% |
| Q3 2022 | $2,272,000 | -0.8% | 121,097 | -1.4% | 0.00% | 0.0% |
| Q2 2022 | $2,290,000 | +23.9% | 122,849 | +20.1% | 0.00% | 0.0% |
| Q1 2022 | $1,849,000 | +70.3% | 102,325 | +95.6% | 0.00% | – |
| Q4 2021 | $1,086,000 | -17.4% | 52,325 | +27.4% | 0.00% | -100.0% |
| Q3 2021 | $1,315,000 | +15.6% | 41,075 | +11.2% | 0.00% | 0.0% |
| Q2 2021 | $1,138,000 | +24.8% | 36,949 | +36.5% | 0.00% | – |
| Q1 2021 | $912,000 | -62.2% | 27,071 | -59.4% | 0.00% | -100.0% |
| Q4 2020 | $2,411,000 | +138.2% | 66,722 | +142.8% | 0.00% | 0.0% |
| Q3 2020 | $1,012,000 | -65.1% | 27,479 | -57.2% | 0.00% | -50.0% |
| Q2 2020 | $2,896,000 | -44.8% | 64,275 | -41.9% | 0.00% | -60.0% |
| Q1 2020 | $5,247,000 | +129.5% | 110,585 | +246.5% | 0.01% | +400.0% |
| Q4 2019 | $2,286,000 | +55.1% | 31,918 | -14.8% | 0.00% | 0.0% |
| Q3 2019 | $1,474,000 | -83.2% | 37,478 | -66.6% | 0.00% | -80.0% |
| Q2 2019 | $8,766,000 | +110.0% | 112,189 | +60.2% | 0.01% | +150.0% |
| Q1 2019 | $4,175,000 | +1841.9% | 70,019 | +1080.0% | 0.00% | – |
| Q3 2018 | $215,000 | -69.7% | 5,934 | -68.4% | 0.00% | – |
| Q2 2018 | $709,000 | +714.9% | 18,786 | +401.6% | 0.00% | – |
| Q1 2018 | $87,000 | +1350.0% | 3,745 | +1021.3% | 0.00% | – |
| Q4 2017 | $6,000 | -99.6% | 334 | -99.8% | 0.00% | -100.0% |
| Q3 2017 | $1,622,000 | +73.8% | 169,056 | +12.1% | 0.00% | 0.0% |
| Q2 2017 | $933,000 | +72.1% | 150,774 | +60.6% | 0.00% | – |
| Q1 2017 | $542,000 | +171.0% | 93,907 | +161.8% | 0.00% | – |
| Q4 2016 | $200,000 | -76.7% | 35,875 | -68.1% | 0.00% | -100.0% |
| Q3 2016 | $860,000 | +27.6% | 112,474 | +22.7% | 0.00% | – |
| Q2 2016 | $674,000 | -64.0% | 91,683 | -41.9% | 0.00% | -100.0% |
| Q1 2016 | $1,874,000 | +1.1% | 157,856 | +40.8% | 0.00% | 0.0% |
| Q4 2015 | $1,853,000 | +23.9% | 112,088 | +53.2% | 0.00% | 0.0% |
| Q3 2015 | $1,495,000 | +38.4% | 73,145 | +82.9% | 0.00% | 0.0% |
| Q2 2015 | $1,080,000 | +48.1% | 40,000 | +33.3% | 0.00% | – |
| Q1 2015 | $729,000 | -37.6% | 30,000 | -62.0% | 0.00% | -100.0% |
| Q4 2014 | $1,168,000 | +38.1% | 78,958 | -13.9% | 0.00% | 0.0% |
| Q3 2014 | $846,000 | -32.3% | 91,658 | -0.5% | 0.00% | 0.0% |
| Q2 2014 | $1,250,000 | +19.0% | 92,125 | +36.5% | 0.00% | 0.0% |
| Q1 2014 | $1,050,000 | – | 67,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |